Back
Predictive Oncology 10K Form
Sell
28
POAI
Predictive Oncology
Last Price:
0.69
Seasonality Move:
-6.32%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-13 | 10Q | POAI/Predictive Oncology Quarterly |
| 2020-06-11 | 10Q | POAI/Predictive Oncology Quarterly |
| 2020-06-08 | 10Q | POAI/Predictive Oncology Quarterly |
| 2020-04-01 | 10K | POAI/Predictive Oncology Annual |
| 2019-11-15 | 10Q | POAI/Predictive Oncology Quarterly |
| 2019-08-19 | 10Q | POAI/Predictive Oncology Quarterly |
Receive POAI News And Ratings
See the #1 stock for the next 7 days that we like better than POAI
POAI Financial Statistics
Sales & Book Value
| Annual Sales: | $1.78M |
|---|---|
| Cash Flow: | $-3.22M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.72 |
| Price / Book: | 1.13 |
Profitability
| EPS (TTM): | -3.35000 |
|---|---|
| Net Income (TTM): | $-14.04M |
| Gross Margin: | $1.15M |
| Return on Equity: | -164.1% |
| Return on Assets: | -93.92% |
Predictive Oncology Earnings Forecast
Key Predictive Oncology Financial Ratios
- The Gross Profit Margin over the past 16 years for POAI is 64.34%.
- The Selling, General & Administrative Expenses for POAI have been equal to 614.54% of Gross Profit Margin.
- The Research & Development expenses have been 187.66% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of POAI is -785.58% of Total Revenues.
- Per Share Earnings over the last 16 years have been positive in 13 years.
Predictive Oncology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | POAI |
| CUSIP: | 74039M |
| Website: | predictive-oncology.com |
Debt
| Debt-to-Equity Ratio: | 0.07 |
|---|---|
| Current Ratio: | 1.49 |
| Quick Ratio: | 1.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
POAI Technical Analysis vs Fundamental Analysis
Sell
28
Predictive Oncology (POAI)
is a Sell
Is Predictive Oncology a Buy or a Sell?
-
Predictive Oncology stock is rated a Sell
The current Predictive Oncology [POAI] share price is $0.69. The Score for POAI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.